The new gold standard
of preclinical testing

Gold standard illustration

Your partner in drug
formulation optimization

Gold standrad illustration
Group picture of the enphasys team
About us

Who we are

Enphasys provides services to evaluate the performance of oral (drug) formulations. Our aim is to accelerate drug development and to provide patients with well functioning and convenient oral drugs. We provide a range of state-of-the-art in vitro assays that evaluate the intestinal performance of various oral drug formulations.

Gold standard illustration
Image of the ENA device

Our invention - ENA

The enabling absorption (ENA) device is a new in vitro tool that captures the complex dynamics between digestion and absorption in the small intestine. The ENA correctly ranks in vivo performance of advanced formulations of any type and the assay also provides mechanistic information to guide further optimization. Put simply, the top performing formulation in the ENA analysis is the one producing the highest oral bioavailability in vivo.

Latest News

New paper published corroborating ENA utility

August 10, 2023
A recent paper further corroborates the utility of Enphasys patented Enabling Absorption Device in evaluating performance of yet another type of oral drug formulation
Read more

Presentation at QRIOS VIP event

June 8, 2023
Enphasys invited to present at the QRIOS VIP event!
Read more

Enphasys selected to represent Swedish innovation in the U.S.

January 18, 2023
Daniel Bergström will represent Enphasys and its ground breaking technology for animal free oral drug formulation lead candidate selection at the upcoming SIREUS Entrepreneurship Forum in Colorado, USA, 14-17 Feb.
Read more
Get in touch!

Contact us for a meeting or
general questions

Thank you! Your submission has been received and we will get back to you as soon as we can!
Oops! Something went wrong while submitting the form.
© 2022 Enphasys AB. All right reserved.  Phent
EU loggo
This project has recieved funding by the European Union's Horizon 2020 research and innovation programme under grant agreement No 836869
Vinnova loggo white